PROM1 and glioblastoma: Relative to their negative counterparts, substantially higher amounts of injected antibody were found on both CD133-overexpressing U251 and HCT116 wild-type cells, the latter expressing CD133 at endogenous levels similar to those of primary CD133+ glioblastoma stem-like cells.